The surge came as Alterity Therapeutics announced positive data from an animal testing of ATH434, a leading drug candidate for Multiple System Atrophy, a degenerative neurological disorder.
The new data “independently confirm and extend previous findings demonstrating that ATH434 reduces α-synuclein pathology, preserves neurons, and improves motor performance,” Alterity Therapeutics noted.
As of this morning, $ATHE is up 174%.
If you want to be included emailed a list of stocks trending on the internet every day, sign up for Goodseed. You get a daily email of stocks that are exploding on the internet as well as access to the on-demand search volume tool where you can research any stock you’d like. You can even get 10 days for free.